RECENT POST

April 29, 2025 00:00 |  

Covington Associates

Covington Associates Announces Advisory Role to Persivia in $107M Recapitalization and Growth Investment from Aldrich Capital Partners

View News

October 12, 2015 06:38 AM  |   Covington Associates

Locemia Solutions acquired by Eli Lilly and Company

Covington advised Locemia Solutions on the sale of worldwide rights to Locemia’s intranasal glucagon to Eli Lilly and Company (NYSE:LLY).